Retinal and cognitive dysfunction in type 2 diabetes: unraveling the common pathways and identification of patients at risk of dementia
- Conditions
- 10047060cognitief functionerencognitive impairmenttype 2 diabetes
- Registration Number
- NL-OMON54910
- Lead Sponsor
- Fundació Hospital Universitari Vall DHebron, VHIR
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 120
1. Type 2 diabetes
2. 65 years and older
3. Diabetes duration of at least 5 years
4. Mild to moderate non-proliferative diabetic retinopathy (NPDR) or with no
overt retinopathy
5. Able to provide informed consent
1. Previous history of stroke or neurodegenerative diseases
2. Severe NPDR, Proliferative DR (PDR), Diabetic Macular Edema (DME) or other
eye disorders affecting vision besides these complications of DR
3. Previous laser photocoagulation
4. Other diseases which may induce retinal neurodegeneration (e.g. glaucoma).
5. Subjects with a refractive error = ± 6 D.
6. Media opacities that preclude retinal imaging
7. HbA1C > 10% (86 mmol/mol)
8. Severe systemic illness or personal circumstances that would not make it
possible for the patients to fulfil study protocols
Study & Design
- Study Type
- Observational invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>To assess whether retinal sensitivity measured by microperimetry is able to<br /><br>predict cognitive decline and progression to dementia in MCI T2D patients.</p><br>
- Secondary Outcome Measures
Name Time Method